All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| CMTA / Clementia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| SELB / Selecta Biosciences Inc
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NVIV / InVivo Therapeutics Holdings Corp.
|
|
|
|
|
|
|
|
| LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
| CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| FSTX / F-star Therapeutics Inc
|
|
|
|
|
|
|
|
| BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
|
|
|
|
|
|
|
|
| MDGN / Medgenics, Inc.
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
|
|
|
|
|
|
|
|
| US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
|
|
|
|
|
|
|
|
| IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
| ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
| PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
| AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
| INFI / Infinity Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| 451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
| LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| DMTX / Dimension Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
| IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ABYLY / Ablynx NV
|
|
|
|
|
|
|
|
| ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
| GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
| 45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
|
|
|
|
|
|
|
|
| AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
| 74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
| STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US670002AB05 / Novavax, Inc. Bond 3.75% Due 2/1/2023
|
|
|
|
|
|
|
|
| VYGR / Voyager Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
|
|
|
|
|
|
|
|
| CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RARX / Ra Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CERS / Cerus Corporation
|
|
|
|
|
|
|
|
| ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
| 0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
| / Achaogen Inc
|
|
|
|
|
|
|
|
| US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| TTOO / T2 Biosystems, Inc.
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
| AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| IFRX / InflaRx N.V.
|
|
|
|
|
|
|
|
| SGEN / Seagen Inc
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| FLGT / Fulgent Genetics, Inc.
|
|
|
|
|
|
|
|
| MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| QLGN / Qualigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
| TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| EYRYY / Erytech Pharma
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
| IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
